BUPIVACAINE AND EPI

The Defense Logistics Agency awarded delivery order SPE2DP26F7552 to DMS PHARMACEUTICAL GROUP INC under base contract SPE2DX25D9900 for the procurement of 3.000 packages of Bupivacaine and Epinephrine, identified by NSN 6505011277947 and NDC 00409-1749-29, at a unit price of $31.50, resulting in a total contract value of $94.50. The order was issued on July 14, 2026, with delivery required by July 29, 2026, to Fort Bragg, NC, under FOB Destination terms where the contractor assumes all costs and risks until delivery is completed at the specified government facility. The awardee is a certified small, women-owned, and small disadvantaged business, triggering federal reporting obligations under relevant socioeconomic programs. Packaging and marking requirements mandate that all shipments use traceable methods, prohibit parcel post, and include the full contract and CLIN identifiers on every package and document, though no specific packaging materials, preservation protocols, or MIL-STD standards are defined. The Government retains responsibility for inspection and acceptance at the destination, and payment will be processed through the Defense Finance and Accounting Service via traditional voucher systems to a P.O. Box in Columbus, Ohio. The sole line item has no quantity variance allowance, and no contract clauses, special requirements, or evaluation factors are evident beyond the administrative and logistical details. The contracting officer is Lisa Quinn, reachable via DLA email, but no Contracting Officer’s Representative or technical point of contact is identified in the documentation.